Results 171 to 180 of about 35,639,582 (304)

Editorial: Advanced data-driven methods for monitoring solar and wind energy systems

open access: yesFrontiers in Energy Research, 2023
Fouzi Harrou   +4 more
doaj   +1 more source

The VHL tumor suppressor at the crossroad of protein folding, aggregation, and cancer

open access: yesMolecular Oncology, EarlyView.
Mutations, environmental stress, and chaperone dysfunction can destabilize pVHL, promoting its conversion from the native folded state into amyloid‐like assemblies. This transition may contribute to protein storage, cell dormancy, survival, and drug resistance.
Lara Abad   +2 more
wiley   +1 more source

From Model-based to Data-driven LMI-based Controller Synthesis [PDF]

open access: yes
openThis thesis uses Linear Matrix Inequalities (LMIs) to transition from model-based to data-driven control design, while preserving guarantees with regard to stability and performance of the resulting closed-loop system.
KRASSOWIZKIY, MICHAEL
core  

An algorithm for closed-loop data-driven simulation

open access: yes
Closed-loop data-driven simulation refers to the problem of constructing trajectories of a closed-loop system directly from data of the plant and a representation of the controller.
Markovsky, Ivan
core   +1 more source

Extracellular vesicle lipidomics liquid biopsy reveals systemic and tumor microenvironment metabolic reprogramming in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani   +9 more
wiley   +1 more source

Synthetic Expansion of Blood Dielectric Spectra at Microwave Frequencies Using Data-Driven Methods. [PDF]

open access: yesSensors (Basel)
Alhummada I   +5 more
europepmc   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

open access: yesMolecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy